On June 23, 2026, the US Department of Justice (DOJ) announced the results of its 2026 National Health Care Fraud Takedown, the largest in DOJ history by several measures. The action resulted in charges against 455 defendants, including 90 doctors and other licensed medical professionals, in connection with over US$6.5 billion in false claims. The DOJ and other agencies brought cases in 56 federal districts across 45 US states and territories, with 50 state Medicaid Fraud Control Units participating—the most in DOJ history. For Medicaid specifically, this takedown was the DOJ's largest fraud enforcement action to date, with 295 defendants charged in connection with more than US$518 million in false claims.
Key fraud schemes charged
The takedown targeted several fraud categories, the most significant of which was wound care. To that end, 11 defendants across six districts were charged in connection with fraudulent claims involving amniotic wound allografts, with providers alleged to have billed and received billions of dollars from Medicare. According to DOJ, the alleged schemes involved kickbacks for allograft billings that drove medically unnecessary use. Medicare payments for wound allografts have increased exponentially over the last five years, reaching over US$14 billion for allografts in 2025, until the Centers for Medicare & Medicaid Services (CMS) recently adjusted reimbursement rates for allografts and deployed advanced data analytics to expose fraud. Other areas of enforcement focus included opioid diversion and patient harm.
Advanced data analytics and AI drive prosecutions
A central theme of this takedown is the government's shift toward proactive, data-driven enforcement. CMS has signaled a move from after-the-fact prosecution to proactive prevention, using advanced data analytics to identify fraud networks, freeze suspicious payments and stop bad actors before they harm federal programs. DOJ's Health Care Fraud Unit announced its first prosecution arising from its new Data Fusion Center's Financial Intelligence Review Team, underscoring the government’s increasing use of integrated data and financial analytics. The case involved an alleged US$67 million scheme to bill Illinois Medicaid for behavioral health services that were never provided, and the investigation was opened within five days of the financial intelligence review. The same emphasis on speed and analytics is reflected in DOJ and CMS’s agreement to give the Fraud Division cloud computing space within the CMS Integrated Data Repository, where it can deploy advanced data analytics algorithms and artificial intelligence tools.
Expanded international reach and new enforcement structures
The government is also signaling that no fraudster, domestic or foreign, is beyond its reach. On June 4, 2026, the FBI announced the creation of its Most Wanted Fraudsters List. One fugitive listed in connection with a US$1.2 billion telemedicine and durable medical equipment scheme was apprehended in the Philippines just four days later. DOJ credited the governments of Estonia, the Philippines and Turkey for their cooperation in apprehending fugitives and defendants involved in health care fraud.
The takedown follows on DOJ’s April 7, 2026, announcement creating the National Fraud Enforcement Division, which DOJ linked to President Trump's Task Force to Eliminate Fraud, chaired by Vice President J.D. Vance. It also sits within a broader enforcement infrastructure dating back to March 2007, when the Health Care Strike Force program began. Since then, the program has charged more than 6,200 defendants, with more than US$45 billion in billed amounts, a track record the government is clearly looking to build on and extend.
Conclusion
The DOJ, through the newly created National Fraud Enforcement Division, has made its commitment to aggressive, data-driven health care fraud enforcement unmistakably clear. Clients operating in the hospice and wound care sectors should take particular note. The government has singled out amniotic wound allograft billing as a primary enforcement target. Providers and investors in these spaces are well advised to conduct prompt and thorough compliance reviews.
Moreover, the scale and sophistication of this takedown signal that scrutiny of these sectors will only intensify. Assistant Attorney General Colin M. McDonald of the DOJ’s National Fraud Enforcement Division stated, “We are aggressively scaling our offensive against anyone using health care as a front to steal from the American people. As today’s cases and arrests show, there is no case too big, no scheme too complex, and no hiding place too remote for our relentless fraud-fighting team. Our message is simple: if you put profit over patients, you should expect to be put in prison.”
Norton Rose Fulbright’s experienced Healthcare Investigations team represents businesses and executives in government investigations. If you find yourself involved in a government investigation or receive a government subpoena or civil investigative demand (CID), our team will defend your interests aggressively and effectively. Please let us know what we can do to help.
This alert is based on the DOJ Office of Public Affairs press release dated June 23, 2026.